Published 4 years ago

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Summary by Reuters

- Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the U.S. biotech firm's potential COVID-19 vaccine and it expects to begin early-stage human trial of the vaccine by the end of 2020 in the UK. Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally rather than via

0 Articles

All

Left

Center

Right

Times of India

Coronavirus vaccine: India's Serum Institute starts manufacturing Codagenix's potential Covid-19 vaccine

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the US biotech firm's potential Covid-19 vaccine and it expects to begin early-stage human trial by the end of 2020 in the UK. Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally.

4 years ago·India

Read Full Article

Reuters

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

4 years ago·United Kingdom

Read Full Article

Today

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the U.S. biotech firm's potential COVID-19 vaccine and it expects to begin early-stage human trial of the vaccine by the end of 2020 in the UK.

4 years ago·Singapore

Read Full Article

Moneycontrol

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

Serum Institute has received necessary regulatory approval from the Review Committee on Genetic Manipulation (RCGM) of India's Department of Biotechnology (DBT) for manufacturing Codagenix's COVID-19 vaccine candidate. It is one of the first to use a weakened version of the coronavirus, unlike other vaccine candidates.

4 years ago·India

Read Full Article

PR Newswire

Serum Institute of India Initiates Manufacturing of Codagenix's Intranasal Live-Attenuated COVID-19 Vaccine Candidate

/PRNewswire/ -- Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced that...

4 years ago·United States

Read Full Article

India TV News

Serum Institute starts manufacturing Codagenix's potential coronavirus vaccine

Serum Institute of India (SII), world's largest vaccine producer in terms of number of doses, has started manufacturing US biotech firm Codagenix Inc's potential coronavirus vaccine. The initial phase human trials of the vaccine are expected to begin by the end of 2020 in UK.

4 years ago·India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right3Center2Last Updated4 years agoBias Distribution

60% Right

Bias Distribution

60% of the sources lean Right

60% Right

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

0 Articles

0 Articles

Coronavirus vaccine: India's Serum Institute starts manufacturing Codagenix's potential Covid-19 vaccine

Coronavirus vaccine: India's Serum Institute starts manufacturing Codagenix's potential Covid-19 vaccine

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

Serum Institute of India Initiates Manufacturing of Codagenix's Intranasal Live-Attenuated COVID-19 Vaccine Candidate

Serum Institute of India Initiates Manufacturing of Codagenix's Intranasal Live-Attenuated COVID-19 Vaccine Candidate

Serum Institute starts manufacturing Codagenix's potential coronavirus vaccine

Serum Institute starts manufacturing Codagenix's potential coronavirus vaccine

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics